Historical Stock Price
RIGL historical stock prices picture
Rigel Pharmaceuticals (RIGL) has the following price history information. Looking back at RIGL historical stock prices for the last five trading days, on April 22, 2024, RIGL opened at $1.06, traded as high as $1.14 and as low as $1.06, and closed at $1.13. Trading volume was a total of 3.34M shares. On April 23, 2024, RIGL opened at $1.13, traded as high as $1.17 and as low as $1.12, and closed at $1.14. Trading volume was a total of 520.00K shares. On April 24, 2024, RIGL opened at $1.13, traded as high as $1.16 and as low as $1.11, and closed at $1.13. Trading volume was a total of 6.45M shares. On April 25, 2024, RIGL opened at $1.12, traded as high as $1.14 and as low as $1.06, and closed at $1.10. Trading volume was a total of 2.97M shares. On April 26, 2024, RIGL opened at $1.10, traded as high as $1.13 and as low as $1.08, and closed at $1.10. Trading volume was a total of 361.50K shares.

RIGL Historical Stock Prices By Date:

RIGL historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Rigel Pharmaceuticals shares, starting with a $10,000 purchase of RIGL, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/29/2014
End date: 04/26/2024
Start price/share: $3.21
End price/share: $1.10
Dividends collected/share: $0.00
Total return: -65.73%
Average Annual Total Return: -10.16%
Starting investment: $10,000.00
Ending investment: $3,425.29
Years: 10.00
Date Open High Low Close Volume
04/22/2024 $1.06 $1.14 $1.06 $1.13 3.34M
04/23/2024 $1.13 $1.17 $1.12 $1.14 520.00K
04/24/2024 $1.13 $1.16 $1.11 $1.13 6.45M
04/25/2024 $1.12 $1.14 $1.06 $1.10 2.97M
04/26/2024 $1.10 $1.13 $1.08 $1.10 361.50K
Rigel Pharmaceuticals is a biotechnology company focused on discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. Co.'s U.S. Food and Drug Administration approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, an oral spleen tyrosine kinase inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The product is also commercially available in Europe, the U.K. (TAVLESSE) and Canada (TAVALISSE) for the treatment of chronic immune thrombocytopenia in adult patients.
Date Close
04/22/2024$1.13
04/23/2024$1.14
04/24/2024$1.13
04/25/2024$1.10
04/26/2024$1.10
RIGL is categorized under the Healthcare sector; below are some other companies in the same sector:

RIOT Historical Stock Prices
RLYP Historical Stock Prices
RMD Historical Stock Prices
RMTI Historical Stock Prices
RNN Historical Stock Prices
RNVA Historical Stock Prices
RNVAZ Historical Stock Prices
ROCM Historical Stock Prices
ROKA Historical Stock Prices
ROSG Historical Stock Prices

Also explore: RIGL shares outstanding history

Email EnvelopeFree RIGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


RIGL Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.